RESPONSE: Seladelpar Normalizes Alkaline Phosphatase, Reduces Pruritus in PBC
Results from the phase 3 trial showed seladelpar elicited biochemical response, normalized alkaline phosphatase, and reduced pruritus at a greater rate than placebo.
David Assis Terry Horner Gideon Hirschfield Yale School Of Medicine Autoimmune Liver Disease Research Drug Administration
Source: hcplive.com